ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 164 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q1 2016. The put-call ratio across all filers is 1.13 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $6,107,000 | -0.7% | 80,000 | 0.0% | 1.55% | -2.4% |
| Q2 2018 | $6,149,000 | +50.7% | 80,000 | 0.0% | 1.59% | +36.5% |
| Q1 2018 | $4,079,000 | -2.3% | 80,000 | -11.1% | 1.17% | -12.8% |
| Q4 2017 | $4,174,000 | +68.1% | 90,000 | +157.1% | 1.34% | +2.9% |
| Q3 2016 | $2,483,000 | -21.9% | 35,000 | -46.2% | 1.30% | -38.8% |
| Q2 2016 | $3,179,000 | -54.4% | 65,000 | -40.9% | 2.12% | -51.1% |
| Q1 2016 | $6,964,000 | -43.6% | 110,000 | 0.0% | 4.34% | -15.8% |
| Q4 2015 | $12,340,000 | +16.5% | 110,000 | 0.0% | 5.16% | -1.0% |
| Q3 2015 | $10,594,000 | -5.9% | 110,000 | 0.0% | 5.21% | +16.3% |
| Q2 2015 | $11,263,000 | +64.9% | 110,000 | 0.0% | 4.48% | +41.3% |
| Q1 2015 | $6,830,000 | +46.6% | 110,000 | +3.6% | 3.17% | +34.6% |
| Q4 2014 | $4,660,000 | -99.9% | 106,200 | +24.9% | 2.36% | -37.2% |
| Q3 2014 | $4,811,000,000 | +238068.3% | 85,000 | +88.9% | 3.75% | +115.3% |
| Q2 2014 | $2,020,000 | – | 45,000 | – | 1.74% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Iguana Healthcare Management, LLC | 75,000 | $5,084,000 | 2.52% |
| COLUMBIA WANGER ASSET MANAGEMENT LLC | 1,237,825 | $83,900,000 | 1.18% |
| CAPITAL INTERNATIONAL LTD /CA/ | 206,718 | $14,011,000 | 0.91% |
| Cormorant Asset Management, LP | 75,000 | $5,084,000 | 0.74% |
| Capital International Sarl | 107,450 | $7,283,000 | 0.63% |
| Rock Springs Capital Management LP | 159,750 | $10,828,000 | 0.62% |
| Opus Point Partners Management, LLC | 12,201 | $827,000 | 0.61% |
| Hood River Capital Management LLC | 109,629 | $7,431,000 | 0.56% |
| Aureus Asset Management, LLC | 50,740 | $2,927,000 | 0.51% |
| ROCKEFELLER FINANCIAL SERVICES INC | 374,663 | $25,395,000 | 0.51% |